Skip to main content
. 2015 Mar 26;2015:bav015. doi: 10.1093/database/bav015

Table 2.

KEGG pathways enriched significantly in the 113 genes

KEGG pathwaya Adjusted P-valueb
Drug metabolism—other enzymesM 1.37 × 10−42
Metabolic pathwaysM 4.58 × 10−23
Metabolism of xenobiotics by cytochrome P450M 6.63 × 10−22
Steroid hormone biosynthesisM 1.73 × 10−21
Retinol metabolismM 9.48 × 10−21
Drug metabolism—cytochrome P450M 5.10 × 10−20
Bladder cancerD 5.21 × 10−17
Ascorbate and aldarate metabolismM 5.21 × 10−17
Pentose and glucuronate interconversionsM 3.73 × 10−16
ErbB signaling pathwayE 1.73 × 10−15
Porphyrin and chlorophyll metabolismM 6.00 × 10−15
Other types of O-glycan biosynthesisM 9.85 × 10−15
Bile secretionO 9.85 × 10−15
Starch and sucrose metabolismM 4.35 × 10−14
Pancreatic cancerD 4.78 × 10−13
ABC transportersE 5.31 × 10−13
Pathways in cancerD 7.13 × 10−12
Pyrimidine metabolismM 9.97 × 10−12
Prostate cancerD 6.39 × 10−9
Non-small cell lung cancerD 9.90 × 10−9
GliomaD 2.94 × 10−9
Endometrial cancerD 3.63 × 10−7
Renal cell carcinomaD 1.55 × 10−6
MelanomaD 1.60 × 10−6
Gap junctionC 4.99 × 10−6
Cytokine-cytokine receptor interactionE 7.82 × 10−6
GnRH signaling pathwayO 8.13 × 10−6
Focal adhesionC 1.65 × 10−5
Hepatitis CD 2.98 × 10−5
MAPK signaling pathwayE 7.00 × 10−4

aThe capital letters beside the pathway names are the abbreviation of the KEGG category names at the first-level. C, cell communication, E, environmental information processing, D, human diseases, M, metabolism, O, organismal systems.

bAdjusted P-value was corrected from nominal P-values by Benjamini–Hochberg multiple testing corrections.